← Leaderboards
Kara Elizabeth Rudolph
Columbia University Health Sciences
$5,546,220
Attributed
$7,353,572
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,353,572 · 5
By mechanism
R01$6,155,592 · 3
R00$889,152 · 1
K99$308,828 · 1
Top collaborators
- Elizabeth A. Stuart4 shared
- Caleb Hilliard Miles2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Jean G. Ford$9,345,158
- Carlos Blanco$12,631,998
- Muredach P Reilly$136,077,018
- Andrew Einstein$2,529,070
- Richard Mayeux$113,943,785
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsSubgroupFutureCharacteristicsNational Institute Of Drug AbuseLeftOpioid Use DisorderMediationMachine LearningPreventionPoliciesDesignSubstance UseMediatingPreventPropertyEffectivenessAffectStatistical MethodsGenderTarget PopulationsAdultOverdose ReductionCessation Of Life
Grant awards (15)
Role of disability and pain in opioid overdose: mechanism and risk mitigation$598,683
R01 · FY2025 · DA · contact PI
Design and analysis advances to improve generalizability of clinical trials for treating opioid use disorder$584,911
R01 · FY2025 · DA · contact PI
Leveraging harmonized data to improve external validity and efficiency of clinical trials for treating opioid use disorder$524,673
R01 · FY2025 · DA
Role of disability and pain in opioid overdose: mechanism and risk mitigation$599,488
R01 · FY2024 · DA · contact PI
Design and analysis advances to improve generalizability of clinical trials for treating opioid use disorder$584,911
R01 · FY2024 · DA · contact PI
Leveraging harmonized data to improve external validity and efficiency of clinical trials for treating opioid use disorder$564,326
R01 · FY2024 · DA
Role of disability and pain in opioid overdose: mechanism and risk mitigation$604,568
R01 · FY2023 · DA · contact PI
Design and analysis advances to improve generalizability of clinical trials for treating opioid use disorder$584,911
R01 · FY2023 · DA · contact PI
Design and analysis advances to improve generalizability of clinical trials for treating opioid use disorder$770,972
R01 · FY2022 · DA · contact PI
Role of disability and pain in opioid overdose: mechanism and risk mitigation$738,149
R01 · FY2022 · DA · contact PI
Mechanisms linking neighborhood poverty to problematic adolescent drug use$313,933
R00 · FY2021 · DA · contact PI
Mechanisms linking neighborhood poverty to problematic adolescent drug use$327,835
R00 · FY2020 · DA · contact PI
Mechanisms linking neighborhood poverty to problematic adolescent drug use$247,384
R00 · FY2018 · DA · contact PI
Mechanisms Underlying Differential Effects of Neighborhood Poverty on Problematic Adolescent Drug Use$153,238
K99 · FY2017 · DA · contact PI
Mechanisms Underlying Differential Effects of Neighborhood Poverty on Problematic Adolescent Drug Use$155,590
K99 · FY2016 · DA · contact PI